REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Number of holders
158
Total 13F shares, excl. options
28,861,708
Shares change
+1,256,389
Total reported value, excl. options
$571,461,773
Value change
+$24,816,515
Put/Call ratio
33%
Number of buys
73
Number of sells
-81
Price
$19.80

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2014

191 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2014.
REPLIGEN CORP - COMMON STOCK (RGEN) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,861,708 shares of 56,222,082 outstanding shares and own 51% of the company stock.
Largest 10 shareholders include FMR LLC (2,532,805 shares), BlackRock Fund Advisors (2,191,795 shares), Invesco Ltd. (1,727,787 shares), DIMENSIONAL FUND ADVISORS LP (1,336,250 shares), State Street Corp (1,316,157 shares), VANGUARD GROUP INC (1,186,986 shares), Conestoga Capital Advisors, LLC (1,133,493 shares), Ameriprise Financial Inc (1,048,254 shares), BlackRock Institutional Trust Company, N.A. (956,447 shares), and ACADIAN ASSET MANAGEMENT LLC (951,856 shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.